Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjin Sun

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Mediators of Inflammation|August 16, 2017
MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 ExpressionAijun Jia, Yueling Wang, Wenjin Sun, et al.
Frontiers in Public Health|April 24, 2026
Identification of risk factors for heavy clinical burden in electrical workers of highlands: a cross-sectional studyQingqing Su, Qinghua He, Yonglin Fu, et al.
Chemical Science|July 1, 2022
A rechargeable molecular solar thermal system below 0 °CZhichun Shangguan, Wenjin Sun, Zhao-Yang Zhang, et al.
Journal of Viral Hepatitis|December 23, 2022
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real-world analysisWencong Zhang, Mingyou Xing, Wenjin Sun, et al.
Life Sciences|October 7, 2023
Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expressionJingsi Jia, Yu Yuan, Yi He, et al.
BMJ (Clinical Research Ed.)|May 16, 2020
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trialWei Tang, Zhujun Cao, Mingfeng Han, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2022
Loss of MBD2 ameliorates LPS-induced alveolar epithelial cell apoptosis and ALI in mice via modulating intracellular zinc homeostasisJiqiang Liu, Shuo Yao, Jingsi Jia, et al.
International Immunopharmacology|April 30, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Mediators of Inflammation|August 16, 2017
MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 ExpressionAijun Jia, Yueling Wang, Wenjin Sun, et al.
Frontiers in Public Health|April 24, 2026
Identification of risk factors for heavy clinical burden in electrical workers of highlands: a cross-sectional studyQingqing Su, Qinghua He, Yonglin Fu, et al.
Chemical Science|July 1, 2022
A rechargeable molecular solar thermal system below 0 °CZhichun Shangguan, Wenjin Sun, Zhao-Yang Zhang, et al.
Journal of Viral Hepatitis|December 23, 2022
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real-world analysisWencong Zhang, Mingyou Xing, Wenjin Sun, et al.
Life Sciences|October 7, 2023
Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expressionJingsi Jia, Yu Yuan, Yi He, et al.
BMJ (Clinical Research Ed.)|May 16, 2020
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trialWei Tang, Zhujun Cao, Mingfeng Han, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2022
Loss of MBD2 ameliorates LPS-induced alveolar epithelial cell apoptosis and ALI in mice via modulating intracellular zinc homeostasisJiqiang Liu, Shuo Yao, Jingsi Jia, et al.
International Immunopharmacology|April 30, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.
Pageof 5